AbbVie Names Robert A. Michael CEO; Richard A. Gonzalez To Become Executive Chairman
AbbVie Names Robert A. Michael CEO; Richard A. Gonzalez To Become Executive Chairman
艾伯維公司任命Robert A. Michael爲CEO；Richard A. Gonzalez將成爲執行董事長。
- As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman
- Robert A. Michael Joins AbbVie Board of Directors
- 如之前所述，理查德·岡薩雷斯卸任首席執行官，擔任執行董事長。
- 羅伯特·A·邁克爾加入艾伯維公司董事會。
NORTH CHICAGO, Ill., July 1, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors, effective today. As previously announced, Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company's inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.
2024年7月1日，伊利諾伊州北芝加哥/美通社--艾伯維公司（紐交所:ABBV）今日宣佈，羅伯特·邁克爾（Robert A. Michael）已經就任首席執行官（CEO），並於今日加入艾伯維公司的董事會。如此前宣佈，邁克爾先生接替自2013年公司成立以來一直擔任CEO的理查德·岡薩雷斯（Richard A. Gonzalez）。岡薩雷斯先生已成爲董事會的執行主席。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。